IV Iron, Vitamin D, Hypophosphatemia: Questions to help you make a treatment decision

Side effects can be acute or long term (and the long term ones often go undiagnosed)

Iron, Vitamin D and phosphate influence each other

You may have been recommended intravenous iron if you are low ferritin in pregnancy, postpartum, or preconception or if you have anemia that doesn’t respond to other interventions.

Before you decide yes or no—or which formulation to choose—here’s what the current research shows about a real but often-overlooked side effect and how to reduce your likelihood of having it. This directly relates to what I share about circadian and quantum biology.

Start Here: Why IV Iron?

The first question isn’t which IV iron formulation (we’ll get to that). But it’s really whether IV iron is necessary.

I started this Quantum Anemia series because so many people have reached out to me who don’t want to supplement with iron, who can’t tolerate it (nausea, constipation and other side effects), or, they have taken iron and it didn’t work to correct their energy levels or anemia.

Before considering an infusion, most providers first work with oral supplementation.

If you are considering an infusion because you have had problems with oral iron, one thing that may help before you escalate to an infusion:

✔️Oral iron absorption is highly responsive to spacing and timing

✔️Alternate-day dosing (rather than consecutive days) significantly improves iron absorption and reduces gastrointestinal side effects¹

Key point: your gut can only absorb so much iron per dose.

Some estimates actually say in an healthy system, oral absorption is roughly equal to expected loss, or a net neutral.

In this emerging viewpoint, recycling and storage mobilization are more important than intake.

This is why, to me, the first question in cases of anemia ought to be, What is your body doing with the iron it has? I wrote about the research on this here:

Iron absorption, recycling and reducing the risk of toxicity are what I have been teaching about in this series so far.

But, for this post I thought it would be a good idea to talk openly about supplementation.

For example, it may not be well known that taking rest days between oral supplementation doses, seems to lead to increased absorption.

How to get the most out of the iron you get from food (and supplements if taking them):

If your provider is considering IV iron for you and oral supplementation hasn’t worked, here are some questions you could ask:

• Have we addressed absorption barriers (nutrient deficiencies, Vitamin C intake, calcium/phytic acid/sugar intake, timing of meals, circadian rhythms and light exposure)?

• Have we optimized oral iron with proper spacing through rest days?

• Is there a specific clinical reason why oral iron and other strategies won’t work in our timeline?

And there are more questions and tests you can ask for later in this post.

What, besides increasing iron, happens when you get IV iron?

If oral iron isn’t working or isn’t an option and you are anemic or extremely low ferritin, then you’re probably being recommended IV formulations.

First of all: the formulations all are NOT all equal.

First and foremost, I recommend asking which formulation they recommend for your situation and why. Double check if you are on any other medications for potential interactions.

In this post, I particularly want to help you avoid the risk of a condition called hypophosphatemia—a drop in serum phosphate that is estimated to occur in 47-75% of patients who receive with one of the most common IV iron formulations.

While hypophosphatemia is brushed off as a “transient” phenomena, I think it’s worth looking deeper at, especially because it happens through a mechanism involving fibroblast growth factor 23 (FGF23), which tells the body to dump phosphate AND which shuts down the active form of Vitamin D².

Is it worth increasing iron, if doing so in turn decreases active Vitamin D?

Phosphate is also a fundamental element in the body, though less well known than iron or Vitamin D.

Since active form of Vitamin D is rarely tested for (tests are usually done for the storage form instead), and since phosphate is also very rarely tested, when this happens, it usually goes undiagnosed and unrecognized, with the symptoms being attributed to continuation of the anemia rather than the infusion.

Duration and symptoms of hypophosphatemia after iron infusions

Symptomatic presentations include muscle weakness, bone pain, and neurological symptoms in severe cases, though many people remain asymptomatic.

Hypophosphatemia, while often brushed off as “transient,” has been shown to persist for weeks to months in documented cases.

I’ve heard from holistic providers needing to support clients for months after their clients have received iron infusions and then had negative symptoms brushed off and ignored by the primary care provider who isn’t trained to look for them.

Research backs up these anecdotal observations of the difficult long-tail healing after the initial “boost” of an iron infusion.

Some studies document persistence beyond 5–6 weeks, and for pregnant women; impacts on the baby in the womb for pregnant women are beginning to be suspected³. Unfortunately, longer-term follow-up data hasn’t been tracked (to my knowledge—if you have data on this, please email it to me: nikko@brighterdaysdarkernights.com). The lack of data is partly because phosphate monitoring isn’t standardized across clinical trials, and partly because continued or a return of fatigue and weakness or poor outcomes in anemia get attributed to the anemia itself rather than to the side effect of the iron formulations used to treat anemia.

In my jaundice series (navigate to the homepage to find it), I found a similar story where the negative long term consequences of neonatal jandice and the long term consequences of intensive phototherapy can’t be well delineated from the data. And the same story with the intensive Doppler and ultrasound used to monitor postdates babies.

The most common iron infusion formulations

Ferric Carboxymaltose (FCM)—Brand names: Injectafer, others

The majority of patients receiving FCM experience severe hypophosphatemia⁴. The incidence is high enough that updated prescribing information in the US and Europe now warns for it. Symptoms include fatigue and weakness—which overlap so neatly with anemia itself that the condition often goes unrecognized. Some people develop symptomatic hypophosphatemia after a single dose. Others experience persistent drops in phosphate for months, occasionally severe enough to cause osteomalacia (bone softening) and secondary hyperparathyroidism⁵.

Iron Isomaltoside (now called Ferric Derisomaltose) brand name: Monoferric

Randomized controlled trials comparing this formulation to FCM show a significantly lower incidence of hypophosphatemia over the same treatment period⁶. The mechanism appears related to the chemical structure of the iron preparation itself⁷.

Ferumoxytol, brand name: Feraheme

Limited but available data suggests a lower risk profile compared to FCM, though comparative trials are fewer.

Iron Sucrose

Historically used, associated with lower hypophosphatemia risk, though less commonly used for high-dose correction in pregnancy and postpartum contexts.

The Iron, Phosphate, Calcium, Vitamin D Axis

In my Quantum Anemia series, I’ve written about how light exposure, electromagnetic radiation, and the circadian rhythm affect erythropoiesis and iron metabolism. Phosphate is woven through that same story, playing a role in cell membranes, DNA and RNA molecules, energy metabolism, cellular signaling and pH buffering (ie, redox)⁸.

If you’re already working to optimize your circadian rhythm and your redox state through light exposure, grounding, and metabolic timing…

… then depleting active Vitamin D and phosphate through IV iron could undermine that effort and lead you into a similar state of fatigue as you get with anemia, just through a different mechanism.

This is why I recommend talking carefully with your provider about what your longer term plan is.

Questions to ask your provider improve your chance of good outcomes

If you’re considering IV iron, here are some questions you could ask:

1. Which formulation are you recommending and why?

2. Have you checked me for pre-existing vitamin D deficiency, low calcium levels, low phosphate levels or raised parathyroid hormone levels? All of these are associated with a higher risk of adverse reactions to IV iron

3. Will you monitor my serum phosphate before, during, and after infusion? This one is especially important if you get recommended FCM (remember: 47-75% who get this formulation develop the condition), but the risk isn’t zero with the other formulations either

4. If hypophosphatemia develops, what is your protocol for managing it?

5. Are there alternative strategies we should explore first?

6. If I proceed, how will we distinguish between fatigue from residual anemia versus fatigue from a potential drop in active Vitamin D and phosphate?

And always get the full documentation to walk through all the potential side effects and contra indications one by one with your provider.

Are iron infusions bad?

The prescription deserves full information and to be approached with eyes open about which formulation carries lower risk, additional screening for pre-existing deficiencies, and a plan to monitor what happens after infusion if you decide to get one.

Next Steps

1. Watch my recent class all about my 4 pillars and how they can support your efforts to have healthy blood:

2. Review the concepts from this post and my class with your healthcare provider.

3. Ask questions.

4. Share your experience in the community chat.

5. Come to an upcoming live call to talk with others and hear what they have done.

Whatever you choose, this is a decision that deserves to be informed by the emerging science of what IV iron actually does to mineral metabolism and not just by anemia correction alone.

For practitioners: This information is available in open-access and peer-reviewed sources. I’ve listed them below.

I also have a curated library of over 1100+ fascinating studies on topics of anemia, circadian rhythms, fertility, pregnancy, quantum biology and other health topics that might be helpful to you in your practice. More info here.

1. Stoffel, N. U., Zeder, C., Brittenham, G. M., Moretti, D., & Zimmermann, M. B. (2020). Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica, 105(5), 1232–1239. https://doi.org/10.3324/haematol.2019.220830

2. Edmonston, D., Wolf, M. FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nat Rev Nephrol 16, 7–19 (2020). https://doi.org/10.1038/s41581-019-0189-5

3. Amstad, G., & Burkhardt, T. (2025). Iron infusion in pregnancy and dental dysplasia in children—is there a link? Frontiers in Pediatrics, 13, 1583241. https://doi.org/10.3389/fped.2025.1583241

4. Glaspy, J. A., Wolf, M., & Strauss, W. E. (2021). Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome. Advances in Therapy, 38(7), 3531–3549. https://doi.org/10.1007/s12325-021-01770-2

5. Schaefer, B., Würtinger, P., Finkenstedt, A., et al. (2016). Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk. PLOS ONE, 11(12), e0167146. https://doi.org/10.1371/journal.pone.0167146

6. Emrich, I. E., Lizzi, F., Siegel, J. D., et al. (2020). Hypophosphatemia After High-Dose Iron Repletion With Ferric Carboxymaltose and Ferric Derisomaltose—The Randomized Controlled HOMe aFers Study. BMC Medicine, 18(1), 178. https://doi.org/10.1186/s12916-020-01643-5

7. Martens, K. L., & Wolf, M. (2023). Incidence, Mechanism, and Consequences of IV Iron–Induced Hypophosphatemia. Hematology, 2023(1), 636–639. https://doi.org/10.1182/hematology.2023000521

8. Wagner C. A. (2024). The basics of phosphate metabolism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 39(2), 190–201. https://doi.org/10.1093/ndt/gfad188